Answers are grounded in this paper and cite their sources.
Seven mutant alleles of the CCR5 gene were identified in southern Chinese, six of which were novel mutations. The most common was a heterozygous mutant allele (R223Q) found in 21 healthy donors and 20 HIV patients. No significant difference in the mutant frequency was observed between healthy donors (0.044) and HIV patients (0.041), but the frequency was significantly higher in asymptomatic (0.066) than in symptomatic HIV patients (0.019). Homozygous CCR5Δ32 carriers are protected from HIV infection, whereas heterozygotes display slow progression to AIDS [1–3]. The mutations are extremely uncommon in Asian populations [3–6]. We studied the frequencies of CCR5 gene mutations in ethnic southern Chinese and explored the clinical association of specific mutations. A total of 484 ethnic southern Chinese were recruited in Hong Kong. They were divided into three groups: 240 HIV-seronegative healthy donors, 110 asymptomatic HIV-seropositive patients (CDC 1993 category A1–A3) managed for 3.9 ± 3.1 years (mean ± SD, same below) with or without treatment, and 134 HIV patients who had developed symptoms with or without AIDS (category B or C) at any time in the follow-up period (5.2 ± 3.5 years). Blood samples were collected from HIV-positive patients attending the Integrated Treatment Centre, Department of Health, and HIV-negative healthy donors from the blood bank of Queen Mary Hospital. Genomic DNA were extracted from blood samples using QIAamp DNA blood minikits (Qiagen Inc., California, USA). The full length of the CCR5 open reading frame (ORF) gene was amplified using a pair of primers: 5′–GGAGGGCAACTAAATACATTC–3′ and 5′–GGCTGTGTATGAAAACTGCC–3′. The polymerase chain reaction (PCR) products were detected by electrophoresis in a 2% agarose gel. Mutations were detected in PCR products of the full-length CCR5 ORF by automated sequencing using the dye terminator sequencing kit (Applied Biosystems, California, USA) and a pair of overlapping primers: F1–5′–CAACTAAATACATTCTAGGAC–3′, and R1–5′–CTATCGATTGTCAGGAGGATG–3′. The mutations were further confirmed in double strands using two pairs of primers: F2–5′–CTTCTTACTGTCC CCTTCTG–3′, R2–5′–TGAAGATAAGCCTCAC AGCC–3′, F3–5′–CATGGTCATCTGCTACTCG G–3′, and R3–5′–GGCTGTGTATGAAAACTAAG C–3′. Heterozygous mutant alleles G106R, T141, R223Q and S336I were also available for analysis by digestion of the PCR products with restriction endonucleases Bsp 1286I, Bst EV, TspRI and AluI (New England BioLabs, Inc., Massachusetts, USA), respectively. The digested products were examined by electrophoresis in a 2% agarose gel. Mutant allele frequencies were determined by allele counting. The significance of heterogeneity in mutation frequencies among HIV patients and healthy donors was determined by both the chi-square and Fisher's exact tests. Yates’ corrections were applied to improve the approximation of the chi-square test. In our study, seven point mutations were identified (Table 1). Overall, the mutant R223Q was a predominant CCR5 allele identified in 41 of the 484 study subjects (f = 0.042, 95% confidence interval 0.029–0.055). The other six variants were novel mutations present at low frequencies (ranging from 0.002 to 0.006), relative to the wild-type and allele R223Q. A multiple mutation of W153C and S336I was found in only one HIV-negative healthy donor. Alleles T141, R223Q and S336I were located in the second, third and fourth intracellular domain, respectively. Two mutants were located in the third (G106R) and fourth (W153C) transmembrane domain, with the remaining two (K171 and Q194H) in the third extracellular domain. Among the seven variants, five may ultimately result in amino acid changes with different chemical properties (G106R, W153C, Q194H, R223Q and S336I) and the other two were synonymous (T141 and K171). All mutants were heterozygotes as determined by sequencing of the double strands. Four mutants were located at enzyme recognized regions, so that they could be further confirmed by enzyme digestion assay (results not shown).Table 1: CCR5 mutation detected in study subjects.The frequencies of the identified CCR5 mutants were compared between HIV-negative and positive individuals (Table 1). Three of the alleles (G106R, T141 and R223Q) were found in both groups. Two variants (W153C and S336I) were identified in HIV-negative donors only and two (K171 and Q194H) in HIV-positive patients alone. The CCR5 R223Q mutant allele was present at a similar frequency in healthy donors and HIV-positive patients (f = 0.044 and 0.041, respectively; Fisher's exact test: P = 0.462; chi-square: χ2 = 0.068, 1 df, P = 0.794). It is unlikely that they are associated with any resistance to HIV infection. Overall, our results did not lend support to the speculation that there is a positive selection of the CCR5 mutation in southern Chinese individuals. Except for mutant R223Q, none of the other alleles occurred at a frequency high enough for a proper evaluation of its clinical implications. Interestingly, the CCR5 R223Q mutation was more commonly detected in HIV asymptomatic (category A1–A3) than symptomatic patients (category B1–C3) (15/110 versus 5/133, or f = 0.066 versus 0.019, P = 0.006). Furthermore, the mutant carrier patients had remained in the asymptomatic stage for at least 4.6 ± 4.0 years (mean ± SD) or had lived for 6.7 ± 0.6 years in the symptomatic stage, the duration of which was longer than that in the non-carriers of HIV asymptomatic (3.9 ± 3.1 years) and symptomatic (5.2 ± 3.5 years) patients, respectively. On the other hand, only five R223Q allele carriers were found in 39 HIV patients (f = 0.064) who had remained at the A1–A3 stage for at least 7.1 ± 2.7 years (mean ± SD), indicating the rarity of the mutation in long-term non-progressors. In conclusion, mutations in the CCR5 ORF gene were not uncommon in southern Chinese individuals, with the allele R223Q occurring as the predominant mutant at a frequency of 0.042. This observation confirmed previous reports in HIV-negative Chinese and Japanese individuals [4]. The other six mutations were a novel finding in this study. They were unique to southern Chinese individuals, except for the Q194H allele, which was present in two out of 16 HIV-infected Caucasian patients residing in Hong Kong (results not shown). To date at least forty other mutant alleles have been identified in other ethnic populations [7–10], but none was present in our cohort. The results indicated that CCR5 gene mutations are specifically associated with ethnicity, and therefore vary with the geographical location. It is speculative that the R223Q mutation may probably play a role in deferring the progression to AIDS in southern Chinese individuals. As no homozygous mutants have yet been identified, the specific immunopathogenic role of the mutation remains to be investigated. Finally, it has been noted that a majority of the long-term non-progression patients (34/39) were wild-type CCR5 gene carriers, suggesting that other host and virological factors must be at play in determining the clinical course and outcomes of HIV infection.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: